Comparison of Combined Vitrectomy and Triamcinolone to Laser Grid in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Information source: Stavanger University Hospital
Information obtained from ClinicalTrials.gov on February 12, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Branch Retinal Vein Occlusion; Macular Edema
Intervention: Grid Laser (Procedure); Vitrectomy and 20 mg triamcinolone (Procedure)
Phase: Phase 3
Status: Recruiting
Sponsored by: Stavanger University Hospital Official(s) and/or principal investigator(s):
Johan Seland, PhD, Study Director, Affiliation: Stavanger University Hospital
Overall contact:
Vegard Forsaa, MD, Email: forsaa@gmail.com
Summary
The purpose of this study is to determine whether pars plana vitrectomy in combination with
triamcinolone acetate is effective in the treatment of macular edema due to branch retinal
vein occlusion.
Clinical Details
Official title: A Randomized Study Comparing Combined Vitrectomy and Triamcinolone to Laser Grid in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Study design: Treatment, Randomized, Open Label, Parallel Assignment
Primary outcome: Visual acuity (ETDRS)
Secondary outcome: Retinal thickening measured on OCT.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Macular edema secondary to BRVO
- Best Corrected Visual Acuity of ≤ 20/40 on ETDRS chart
- Duration no shorter than 3 months
- Duration no longer than 12 months
Exclusion Criteria:
- Proliferations in study eye
- Blod in vitreous cavity
- Previous fundus laser treatment
- BRVO with over 180˚ of ischemia on FA
- Age under 18
- Other eye condition which contribute to relevant loss of visual acuity
Locations and Contacts
Vegard Forsaa, MD, Email: forsaa@gmail.com
Stavanger University Hospital, Department of Ophthalmology, Stavanger 4018, Norway; Recruiting
Rune Hapnes, MD, Phone: +47 99 44 13 29, Email: hap@sus.no
Vegard Forsaa, MD, Principal Investigator
Additional Information
Starting date: November 2006
Ending date: November 2013
Last updated: June 5, 2008
|
